​
​

bioAffinity (BIAF) Revenue & Revenue Breakdown

OverviewOwnershipFinancialsChart

bioAffinity Revenue Highlights

0

Latest Revenue (Q)

$2.35M

Main Segment (Y)

Other Revenues

bioAffinity Revenue by Period

bioAffinity Revenue by Year

DateRevenueChange
2023-12-31--100.00%
2022-12-31$4.80K100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31--

bioAffinity generated - in revenue during NA 2023, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

bioAffinity Revenue by Quarter

DateRevenueChange
2024-09-30$2.35M-1.97%
2024-06-30$2.40M-0.36%
2024-03-31$2.41M8.72%
2023-12-31$2.21M641.53%
2023-09-30$298.48K1412.23%
2023-06-30$19.74K2043.11%
2023-03-31$921.00-60.74%
2022-12-31$2.35K104.00%
2022-09-30$1.15K-11.94%
2022-06-30$1.31K100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31--

bioAffinity generated $2.35M in revenue during Q3 2024, up -1.97% compared to the previous quarter, and up 11907.92% compared to the same period a year ago.

bioAffinity Revenue Breakdown

bioAffinity Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23
Health Care, Other$19.32K
Other Revenues$21.52K

bioAffinity's latest annual revenue breakdown by segment (product or service), as of Dec 23: Other Revenues (52.68%), and Health Care, Other (47.32%).

Quarterly Revenue by Product

Product/ServiceJun 24Mar 24Dec 23Sep 23Jun 23
Other Revenues$23.92K$427.00---
Health Care, Other$33.19K$16.06K$16.93K$2.39K-
Laboratory Services---$7.42K-
Royalty Income---$5.41K-
Health Care, Patient Service---$248.65K-
Diagnostic Test----$7.00K

bioAffinity's latest quarterly revenue breakdown by segment (product or service), as of Jun 24: Health Care, Other (58.12%), and Other Revenues (41.88%).

bioAffinity Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
GTHGenetron$650.71M$201.32M
BIOCBiocept$25.86M$589.00K
PMDPsychemedics$22.10M$5.17M
PRPOPrecipio$12.40M$4.44M
GENEGenetic$8.69M$3.96M
TTOOT2 Biosystems$7.19M$1.99M
HTGMHTG Molecular Diagnostics$6.37M$1.03M
INBSIntelligent Bio Solutions$3.11M$872.29K
SQLSeqLL$1.18K-
BIAFbioAffinity-$2.35M

BIAF Revenue FAQ

What is bioAffinity’s yearly revenue?

bioAffinity's yearly revenue for 2023 was $0, representing a decrease of -100.00% compared to 2022. The company's yearly revenue for 2022 was $4.8K, representing an increase of 100.00% compared to 2021. BIAF's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.

What is bioAffinity’s quarterly revenue?

bioAffinity's quarterly revenue for Q3 2024 was $2.35M, a -1.97% decrease from the previous quarter (Q2 2024), and a 687.44% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $2.4M, a -0.36% decrease from the previous quarter (Q1 2024), and a 12047.39% increase year-over-year (Q2 2023). BIAF's quarterly revenue for Q1 2024 was $2.41M, a 8.72% increase from the previous quarter (Q4 2023), and a 261180.24% increase year-over-year (Q1 2023).

What is bioAffinity’s revenue growth rate?

bioAffinity's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.

What are bioAffinity’s revenue streams?

bioAffinity's revenue streams in c 23 are Health Care, Other, and Other Revenues. Health Care, Other generated $19.32K in revenue, accounting 47.32% of the company's total revenue Other Revenues generated $21.52K in revenue, accounting 52.68% of the company's total revenue

What is bioAffinity’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of bioAffinity was Other Revenues. This segment made a revenue of $21.52K, representing 52.68% of the company's total revenue.